Literature DB >> 31201715

Hypoxia-Induced Phenotypes that Mediate Tumor Heterogeneity.

Jin Qian1, Erinn B Rankin2,3.   

Abstract

Intratumoral heterogeneity is an important factor contributing to metastasis and therapy resistance. The phenotypic diversity of cancer cells within the tumor microenvironment is strongly influenced by microenvironmental factors such as hypoxia. Clinically, hypoxia and the hypoxia inducible transcription factors HIF-1 and HIF-2 are associated with cancer stem cells, metastasis and drug resistance in multiple tumor types. Experimental models have demonstrated an important functional role for HIF signaling in driving CSC, metastatic and drug resistant phenotypes in vitro and in vivo. Here we will review recent studies that highlight novel mechanisms by which hypoxia promotes cancer stem cell, metastatic and drug resistant phenotypes.

Entities:  

Keywords:  Cancer stem cell; Chemotherapy; HIF; Hypoxia; Metabolism; Metastasis; Stemness; Therapy resistance

Mesh:

Substances:

Year:  2019        PMID: 31201715      PMCID: PMC7039393          DOI: 10.1007/978-3-030-12734-3_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  89 in total

Review 1.  Metastatic stem cells: sources, niches, and vital pathways.

Authors:  Thordur Oskarsson; Eduard Batlle; Joan Massagué
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

2.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.

Authors:  Alexander Pietras; Amanda M Katz; Elin J Ekström; Boyoung Wee; John J Halliday; Kenneth L Pitter; Jillian L Werbeck; Nduka M Amankulor; Jason T Huse; Eric C Holland
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

Review 3.  The dynamic epitranscriptome: N6-methyladenosine and gene expression control.

Authors:  Kate D Meyer; Samie R Jaffrey
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04-09       Impact factor: 94.444

Review 4.  Regulatory networks in embryo-derived pluripotent stem cells.

Authors:  Michele Boiani; Hans R Schöler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

5.  Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.

Authors:  Tingsong Hu; Shanrong Liu; Deborah R Breiter; Fang Wang; Ying Tang; Shuhan Sun
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

6.  Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

Authors:  Balaji Krishnamachary; David Zagzag; Hideko Nagasawa; Karin Rainey; Hiroaki Okuyama; Jin H Baek; Gregg L Semenza
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

7.  HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

Authors:  Kelly L Covello; James Kehler; Hongwei Yu; John D Gordan; Andrew M Arsham; Cheng-Jun Hu; Patricia A Labosky; M Celeste Simon; Brian Keith
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

8.  Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.

Authors:  Debangshu Samanta; Daniele M Gilkes; Pallavi Chaturvedi; Lisha Xiang; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 12.779

9.  Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer.

Authors:  Eun Jin Seo; Dae Kyoung Kim; Il Ho Jang; Eun Jung Choi; Sang Hun Shin; Su In Lee; Sang-Mo Kwon; Ki-Hyung Kim; Dong-Soo Suh; Jae Ho Kim
Journal:  Oncotarget       Date:  2016-08-23

Review 10.  Hypoxia-inducible factors, stem cells, and cancer.

Authors:  Brian Keith; M Celeste Simon
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

View more
  14 in total

1.  Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling.

Authors:  Jin Qian; Bauer L LeSavage; Kelsea M Hubka; Chenkai Ma; Suchitra Natarajan; Joshua T Eggold; Yiren Xiao; Katherine C Fuh; Venkatesh Krishnan; Annika Enejder; Sarah C Heilshorn; Oliver Dorigo; Erinn B Rankin
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

Review 2.  Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.

Authors:  Plabon Kumar Das; Suja Pillai; Md Abdur Rakib; Jahan Ara Khanam; Vinod Gopalan; Alfred K Y Lam; Farhadul Islam
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

3.  Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer.

Authors:  Vineet K Gupta; Nikita S Sharma; Brittany Durden; Vanessa T Garrido; Kousik Kesh; Dujon Edwards; Dezhen Wang; Ciara Myer; Beatriz Mateo-Victoriano; Sai Sundeep Kollala; Yuguang Ban; Zhen Gao; Sanjoy K Bhattacharya; Ashok Saluja; Pankaj K Singh; Sulagna Banerjee
Journal:  Cancer Res       Date:  2021-05-14       Impact factor: 12.701

Review 4.  Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.

Authors:  Rongbin Ge; Zongwei Wang; Liang Cheng
Journal:  NPJ Precis Oncol       Date:  2022-05-04

Review 5.  Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.

Authors:  He-Ming Zhou; Ji-Gang Zhang; Xue Zhang; Qin Li
Journal:  Signal Transduct Target Ther       Date:  2021-02-15

6.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

Review 7.  Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies.

Authors:  Qi Zhang; Yu Lou; Xue-Li Bai; Ting-Bo Liang
Journal:  World J Gastroenterol       Date:  2020-07-14       Impact factor: 5.742

8.  Role of hypoxia inducible factor-1 in cancer stem cells (Review).

Authors:  Qi Zhang; Zhenzhen Han; Yanbo Zhu; Jingcheng Chen; Wei Li
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

Review 9.  Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective.

Authors:  Abdellah Akil; Ana K Gutiérrez-García; Rachael Guenter; J Bart Rose; Adam W Beck; Herbert Chen; Bin Ren
Journal:  Front Cell Dev Biol       Date:  2021-02-16

10.  Lung Adenocarcinoma Transcriptomic Analysis Predicts Adenylate Kinase Signatures Contributing to Tumor Progression and Negative Patient Prognosis.

Authors:  Jonathan A Chacon-Barahona; Ivan A Salladay-Perez; Nathan James Lanning
Journal:  Metabolites       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.